Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.200NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.200NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.299NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BF.7.21NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BF.7.21NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BF.7.13.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BF.7.13.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BF.37NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BF.37NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CK.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CK.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CM.5NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CM.5NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBC.1.3.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBC.1.3.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.208NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.208NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.197NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.197NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.491NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.491NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
EV.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EV.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
P.1.8 (Gamma)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
P.1.8 (Gamma)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
AY.39.3 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
AY.39.3 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.351.3 (Beta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.351.3 (Beta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.318NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.318NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
R.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
R.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
AY.29 (Delta)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
AY.29 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
ML.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
ML.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.169NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.169NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.53NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.53NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.4.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.4.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.528NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.528NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.175NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.175NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.6.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.6.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BF.7.19.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used